Association between ABO Blood Groups, Carotid Stenosis and Atherosclerotic Plaque Burden: A Retrospective Cohort

Joy Chowdhury1, Aditya Sikand2, J David Spence2

  • 1Western University, Robarts Research Institute Stroke Prevention and Atherosclerosis Research Centre, Canada.

Insights

ABO blood groups are not linked to carotid atherosclerosis. This study found no association between blood types and plaque buildup or artery narrowing. Focus on lifestyle factors for vascular health.

Area of Science:

  • Cardiovascular Research
  • Medical Genetics
  • Epidemiology

Background:

  • Previous research suggests potential links between specific blood groups and vascular diseases.
  • However, limited studies have explored the association between atherosclerosis and ABO blood groups.
  • This study aimed to investigate the relationship between ABO blood groups and carotid atherosclerosis.

Purpose of the Study:

  • To determine if ABO blood groups are associated with the presence and severity of carotid atherosclerosis.
  • To analyze the correlation between different blood groups and carotid plaque burden.
  • To assess the impact of blood groups on arterial stenosis.

Main Methods:

  • A retrospective cohort study involving 3855 patients from 1985 to 2021.
  • Carotid plaque burden measured by total plaque area and percent stenosis.
  • Statistical analyses included quantile regression and logistic regression, adjusting for cardiovascular risk factors.

Main Results:

  • No significant associations were found between ABO blood groups and total plaque area.
  • Carotid stenosis (≥50% vs. <50%) showed no association with ABO blood groups.
  • In patients with existing cardiovascular disease, blood groups were not linked to total plaque area.

Conclusions:

  • ABO blood groups are not associated with carotid atherosclerosis.
  • Current findings suggest that blood type is not a predictor of carotid atherosclerosis.
  • Prevention strategies should prioritize modifiable risk factors and healthy lifestyle choices for vascular health.
Abstract

Related Concept Videos

Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...